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Abstract
An important morphological criterion for the development of the degree of malignancy of breast cancer is the
change in the structure of cell nuclei. At the same time, both the morphometric parameters of metachronous
breast cancer and their connection with the molecular biological characteristics of these tumors are currently
unknown.
The objective of the research was to identify metachronous malignant disease in the patients with breast cancer.
Materials and methods. The study is based on a retrospective analysis of tumors in 63 patients with breast
cancer, who developed uterine cancer or ovarian cancer within 5 years after diagnosis of breast cancer. All the
patients received treatment at the Ivano-Frankivsk Regional Clinical Oncology Center. The criterion for selecting
patients in the study was the presence of gynecologic cancer after the treatment of breast cancer. The age of
patients with breast cancer involved in the study ranged from 24 to 83 years, averaging 56.8±1.5 years.
Results and discussion. The maximum values of the perimeter, radius, and area of cell nuclei (19.21±0.7,
3.05±0.4 and 36.3±0.9, respectively) were observed in tumors of the patients with metachronous breast cancer.
The improvement of the perimeter, radius, and area of tumor cell nuclei in the patients with metachronous breast
cancer was associated with an increase in the size of the tumors and the presence of metastases in regional
lymph nodes.
Conclusions. The morphometric sign of the high risk of developing metachronous breast cancer is the increase
in the perimeter, radius, and cell nucleus area on the background of increased proliferative activity of low-grade
cancer in the presence of large tumors and metastases in regional lymph nodes.
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Problem statement and analysis of
the latest research
Breast cancer (BC) is the most common cancer in
women in Ukraine and worldwide with high mor-
bidity and mortality rates and a tendency for steady
growth. According to the American Cancer Society
(2015), there are two peak periods of developing
one more tumor in patients with BC: 1 month - 1
year, 3 - 4 years after the treatment of BC [1].
In 73% of BC cases, two mammary glands are
involved in the pathological process; in 18% of the
patients, another tumor is localized in the genitals;
in 7% of the cases, tumor develops in the gastroin-
testinal tract; in 4% of the patients, tumor is local-
ized in the skin and other organs. The etiology of
BC is multifactorial. Among the well-established
etiological factors, the impairment of endocrine
interconnections plays a critical role. Mammary
gland tumors are hormonal and hormone depen-
dent. To such tumors, we include a significant
part of BC, as well as tumors of the uterus and
Morphometric Characteristics and Features of Metachronous Breast Cancer — 2/6
ovaries. The main common factor for all of the
above-mentioned tumors, apart from the factors of
metabolic nature, is latent or apparent chronic hy-
perestrogenemia [1, 2, 3].
Metachronous BC accounts for 69.6% of all
primary multiple tumors and ranks first among them.
According to various authors, the frequency of its
occurrence in relation to the total number of the
patients with BC varies from 12 to 28% [3, 4].
The lack of the objective criteria for predicting
the onset of secondary illness in the patients with
BC requires further investigation of the biological
characteristics of this pathology in order to identify
the risk factors and predict the course of the disease
[5].
In recent years, the prognosis of the course of
metachronous BC has been carried out based on
studying the expression of a number of molecular
markers. Change in the structure of cell nuclei is
known to be an important morphological criterion
for the development of the degree of BC malignancy.
At the same time, the morphometric parameters of
metachronous BC are currently unknown and their
connection with the molecular biological character-
istics of these tumors is not determined [6, 7, 8].
The nuclei of malignant cells usually exhibit a
variation in the size that is known as pleomorphism.
According to the theory of mutant phenotype, ge-
netic instability occurs at the early stages of carcino-
genesis, and leads to the formation of subclones of
cells with different mutations. As a consequence,
heterogeneous population of cells with variations in
the size and shape of the nucleus is observed. The
determination of these variations has both diagnos-
tic and prognostic value for predicting oncological
diseases [7, 8, 9].
The objective of the research was to study the
morphometric characteristics of metachronous BC
and to find out the possibility of using these indica-
tors to predict the course of the tumor process.
1. Materials and Methods
The study is based on a retrospective analysis of tu-
mors in 63 patients with BC, who developed uterine
cancer (UC) or ovarian cancer (OC) within 5 years
after diagnosis of breast cancer. All the patients
received treatment at the Ivano-Frankivsk Regional
Clinical Oncology Center. The criterion for select-
ing patients in the study was the presence of gyne-
cologic cancer after the treatment of breast cancer.
The age of patients with breast cancer involved in
the study ranged from 24 to 83 years, averaging
56.8 ± 1.5 years.
The characteristics of the patients by age are pre-
sented in Table 1. The patients at the age of 50-59
years prevailed amounting for 28.6% of the cases;
the patients at the age of 60-69 years accounted for
23.8% of the cases. The average age of the patients
was 56.8 ± 1.5 years.
Table 1. Distribution of the patients with BC by
age.
Age, years Patients with BC
abs. %
20-29 1 1.6
30-39 6 9.5
40-49 12 19.0
50-59 18 28.6
60-69 15 23.8
70-79 9 14.3
80-89 2 3.3
Total 63 100
Average age 56.8±1.5
Histological preparations of tumors were used
for the measurement [9]. The indicators such as
the perimeter, radius, and area of tumor cell nuclei
were selected [10].
A microscope LM Carl Zeiss (PrimStar) was
used to visualize the preparations [9]. The pictures
were taken using a Canon camera. The measure-
ments were carried out using the microscope soft-
ware AxioVision. For the calculation of statistical
indicators, the sampling size was 100 measurements
for each geometric index [9, 10].
Statistical processing of the results obtained was
carried out by means of the mathematical program
of biomedical statistics STATISTICA 6.0. Student’s
t-test was used to assess the reliability of the dif-
ferences in the expression of the examined markers
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and other clinical and pathological parameters. The
difference was considered statistically significant at
p<0.05.
2. Results and Discussion
Among the patients with BC, 47 (74.6%) patients
developed UC, and 16 (25.4%) patients were diag-
nosed with OC.
Most patients with BC (47 individuals - 74.6%)
developed UC after treatment (Fig. 1).
Figure 1. Distribution of the patients with BC
according to the development of metachronous
disease.
We also analyzed the patients according to the
stage of BC (TNM classification, 2002) (Table 2).
Table 2. Distribution of the patients with BC by
the stage of the disease.
BC stage, FIGO staging Patient with BC, %
Stage I: T1N0M0 17 (27.0)
Stage II: T0-3N0-1M0 32 (50.8)
Stage III: T0-4N0-3M0 12 (19.0)
Stage IV: T0-4N0-3M1 2 (3.2)
Total 63 (100)
Among these patients, stage I and II BC were
detected most often - 27.0% and 50.8% of the cases,
respectively; stage III BC was found in about 19.0%
of the cases.
By the degree of differentiation, tumors were
divided into well differentiated (G1), moderately
differentiated (G2) and poorly differentiated (G3)
tumors (Table 3).
Table 3. Distribution of the patients by the degree
of tumor differentiation.
Stage differentiation G, (%)
G1 18 (28.6)
G2 37 (58.7)
G3 8 (12.7)
Total 63 (100)
Among the patients with BC, moderately dif-
ferentiated tumor was most frequently detected -
58.7% of the cases; well differentiated tumor was
found in 28.6% of the cases; poorly differentiated
tumor was less common - 12.7% of the patients.
When analyzing the morphometric character-
istics of cell nuclei, the maximum values of the
studied parameters, perimeter, radius, and area of
tumor cell nuclei were determined (Table 4).
Table 4. Morphometric characteristic of nuclei of
tumor cells in patients with breast cancer.
Parameter
Perimeter,
µm
Radius,
µm
Area,
µm2
Patients
with BC
19.21±0.7 3.050±0.4 36.3±0.9
The correlation of the morphometric parameters
of tumor cell nuclei with clinical and pathological
characteristics of BC such as tumor size, the pres-
ence of metastatic lesions of regional lymph nodes
and the degree of differentiation was determined.
An increase in tumor size was found to be as-
sociated with an increase in the perimeter, radius
and area of tumor cells in the patients. In the pa-
tients with T3 tumors, the perimeter, radius, and
area of tumor cell nuclei were 21.6±1.8, 3.4±1.0
and 45.9±1.3, while in the patients with T2 and T1
tumors, they were 13.8±0.9, 2.2±0.8 and 18.1±0.9
and 14.3±1.1, 2.2±0.8 and 18.5±1.2, respectively
(Table 5).
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Table 5. Morphometric characteristics of cell
nuclei of BC depending on tumor size.
Parameter
Tumor
size
Perimeter,
µm
Radius,
µm
Area,
µm2
T1 14.3±1.1* 2.2±0.8* 18.5±1.2*
T2 13.8±0.9* 2.2±0.8* 18.1±0.9*
T3 21.6±1.8 3.4±1.0 45.9±1.3
Note: * – p<0.05 as compared to T3 tumors.
In addition, an increase in the perimeter, ra-
dius, and diameter of BC cell nuclei was found to
be associated with the presence of metastatic in-
volvement of regional lymph nodes. In the patients
without metastatic involvement of regional lymph
nodes, the perimeter, radius, and area of tumor
cell nuclei were 10.9±0.8, 1.7±0.6 and 9.7±1.0,
while in the patients with N1 and N2 BC, they
were greater - 14.02±1.3, 2.2±0.3, 17.2±0.9 and
19.3±1.0, 3.07±0.7, 37.6±1.1, respectively (Table
6).
Table 6. Morphometric characteristics of BC cell
nuclei depending on the presence of metastatic
lesions of regional lymph nodes.
Parameter
Metastatic
lesions of
regional
lymph
nodes
Perimeter,
µm
Radius,
µm
Area,
µm2
N0 10.9±0.8* 1.7±0.6* 9.7±1.0*
N1 14.02±1.3 2.2±0.3 17.2±0.9
N2 19.3±1.0 3.07±0.7 37.6±1.1
Note: * – p<0.05 as compared to N1 and N2 tumors.
A decrease in the degree of BC differentiation
was found to be accompanied by an increase in all
investigated parameters of tumor cell nuclei in the
patients of the studied group (Table 7). Thus, in the
patients with well, moderate and poor degree of BC
differentiation, the perimeter of tumor cell nuclei
was 12.5±0.7, 18.9±0.7 and 19.9±0.7 µm. The
decrease in the degree of BC differentiation was
associated with the increase in the radius and the
area of tumor cells as well.
Table 7. Morphometric characteristics of cell
nuclei depending on the degree of differentiation of
breast cancer cells.
Parameter
Degree of
differenti-
ation
Perimeter,
µm
Radius,
µm
Area,
µm2
G1 12.5±0.9* 1.9±0.9* 15.2±0.8*
G2 18.9±1.0 3.0±0.4 36.2±0.8
G3 19.9±0.8 3.1±0.7 39.1±1.2
Note: * – p<0.05 as compared to moderately and poorly
differentiated tumors.
When analyzing the dependencies of the mor-
phometric indices of tumor cell nuclei on their re-
ceptor status and proliferative activity, certain differ-
ences were determined. The studied morphometric
parameters were found not to depend on the pres-
ence of the expression of estrogen and progesterone
receptors in tumor cells of the patients (Table 8).
High proliferative activity of BC in the patients
was found to be associated with an increase in the
perimeter, radius and cell nucleus area by 1.5-2
times.
The next stage of the research was to study the
correlation between the morphometric indices of
BC cell nuclei according to the period of occurrence
and localization of another tumor. There was no
statistically significant difference between the mor-
phometric characteristics of BC and the period of
occurrence of secondary illness (Table 9).
The maximum indicators of the perimeter, ra-
dius and area of cell nuclei were determined in the
patients with BC and localization of another neo-
plasm in the ovary (Table 10).
3. Conclusions
The maximum values of the perimeter, radius, and
area of cell nuclei (19.21±0.7, 3.05±0.4 and
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Table 8. Morphometric characteristics of cell
nuclei depending on the degree of differentiation of
breast cancer cells.
Parameter
Expression
of molec-
ular
markers
Perimeter,
µm
Radius,
µm
Area,
µm2
ER (-) 15.5±0.9 2.4±0.9 24.0±0.8
ER (+) 19.9±1.0 3.1±0.4 24.4±0.8
PR (-) 15.5±0.8 2.4±0.7 24.7±1.2
PR (+) 19.9±0.9 3.1±0.9 27.0±0.8
Ki-67(-) 13.5±1.0 2.1±0.4 24.4±0.8
Ki-67 (+) 29.9±0.8* 3.6±0.7* 40.7±1.2*
Note: * – p<0.05 as compared to Ki-67 (-) tumors.
Table 9. Morphometric characteristics of cell
nuclei depending on the degree of differentiation of
breast cancer cells.
Parameter
Another
tumor oc-
currence
Perimeter,
µm
Radius,
µm
Area,
µm2
Within 1
year
17.4±1.9 2.7±0.9 29.1±1.8
Within 3
years
18.3±1.0 2.9±0.6 35.9±1.6
More than
3 years
19.5±1.8 3.1±0.7 36.5±1.2
Table 10. Morphometric characteristics of cell
nuclei depending on localization of another tumor
in the patients with BC.
Parameter
Localiza-
tion of
another
tumor
Perimeter,
µm
Perimeter,
µm
Perimeter,
µm
UC 20.1±2.1 3.2±0.6 40.2±2.8
OC 12.2±1.0 1.94±0.4 14.6±1.6
36.3±0.9, respectively) were observed in tumors of
the patients with metachronous breast cancer.
The increase in the perimeter, radius, and area of
tumor cell nuclei in the patients with metachronous
breast cancer was found to be associated with an
increase in the size of the tumors and the presence
of metastases in regional lymph nodes.
The decrease in the degree of BC differentiation
was found to be accompanied by an increase in
all studied parameters of tumor cell nuclei in the
patients of the studied group.
High proliferative activity of BC in the patients
was found to be associated with an increase in the
perimeter, radius and cell nucleus area by
1.5-2 times.
The morphometric sign of the high risk of de-
veloping disease secondary to BC is the increase
in the perimeter, radius, and cell nucleus area on
the background of increased proliferative activity
of low-grade cancer in the presence of large tumors
and metastases in regional lymph nodes.
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